her2

Explore academic connections and research related to this keyword

254

Views

20

Total Connections

Search More Keywords

Related Articles & Bibliographies

1

The Pattern of Signatures in Gastric Cancer Prognosis.

Machlowska, Julita;Maciejewski, Ryszard;Sitarz, Robert;

2018 International journal of molecular sciences DOI: E1658 270 views

2

Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.

Saunus, Jodi M;Quinn, Michael C J;Patch, Ann-Marie;Pearson, John V;Bailey, Peter J;Nones, Katia;McCa...

2015 the journal of pathology DOI: 10.1002/path.4583 269 views

3

clinical utility of her2 assessed by immunohistochemistry in patients undergoing curative resection for gastric cancer

;Liu X;Xu P;Qiu H;Liu J;Chen S;Xu D;Li W;Zhan Y;Li Y;Chen Y;Zhou Z;Sun X

2016 jurnal tam 324 views

4

tailoring dna vaccines: designing strategies against her2 positive cancers

;Cristina eMarchini;Cristina eKalogris;Chiara eGarulli;lucia ePietrella;Federico eGabrielli;Claudia...

2013 international journal of heat and technology DOI: 10.3389/fonc.2013.00... 164 views

5

the coexpression and prognostic significance of c-met, fibroblast growth factor receptor 2, and human epidermal growth factor receptor 2 in resected gastric cancer: a retrospective study

;Jia YX;Li TF;Zhang DD;Fan ZM;Fan HJ;Yan J;Chen LJ;Tang H;Qin YR;Li XY

2016 jurnal tam 195 views

6

immunohistochemical assessment of her2 expression in gastric cancer in a cohort of 118 brazilian patients

;Juliana Elizabeth Jung;Sérgio Ossamu Ioshii

2013 industrial and engineering chemistry research DOI: 10.1590/S1676-244420... 117 views

7

association between cln3 (neuronal ceroid lipofuscinosis, cln3 type) gene expression and clinical characteristics of breast cancer patients

;Rose-Mary eBoustany;Joelle eMakoukji;Mohamad eRaad;Katia eGenadry;Sally eEl-Sitt;Nadine J. Makhoul;...

2015 international journal of heat and technology DOI: 10.3389/fonc.2015.00... 179 views

8

liquid biopsy prevents inaccurate her2 status determination by in situ hybridization in a patient with invasive ductal adenocarcinoma of the breast: case report

;Yen-Dun Tony Tzeng;Shih-En Chang;Rui Mei;Manana Javey

2017 multi-span large bridges - proceedings of the inte... DOI: 10.1159/000480698 159 views

9

structure based antibody-like peptidomimetics

;Mark I. Greene;Ramachandran Murali

2012 journal of cerebral blood flow and metabolism DOI: 10.3390/ph5020209 195 views

10

improved aptamers for the diagnosis and potential treatment of her2-positive cancer

;Marlies Gijs;Gregory Penner;Garth B. Blackler;Nathalie R.E.N. Impens;Sarah Baatout;André Luxen;An M...

2016 journal of cerebral blood flow and metabolism DOI: 10.3390/ph9020029 270 views

11

response to her2 inhibition in a patient with brain metastasis with egfr tki acquired resistance and an her2 amplification

;Arenda D. Meedendorp;Arja ter Elst;Nils A. ’t Hart;Harry J. M. Groen;Ed Schuuring;Anthonie J. van d...

2018 international journal of heat and technology DOI: 10.3389/fonc.2018.00... 178 views

12

omics and immunologic approaches to optimizing cure rates in her2-positive breast carcinomas.

;Elda eTagliabue;Manuela eCampiglio

2014 international journal of heat and technology DOI: 10.3389/fonc.2014.00... 188 views

13

pre-clinical assessment of 177lu-labeled trastuzumab targeting her2 for treatment and management of cancer patients with disseminated intraperitoneal disease

;Diane E. Milenic;Paul S. Albert;Martin W. Brechbiel;Lanea M. M. Keller;Kwamena E. Baidoo;Geoffrey L...

2011 journal of cerebral blood flow and metabolism DOI: 10.3390/ph5010001 213 views

14

First-in-human phase 1 study of margetuximab (MGAH22), an Fc-modified chimeric monoclonal antibody, in patients with HER2-positive advanced solid tumors

Y. J. Bang,G. Giaccone,S. A. Im,D. Y. Oh,T. M. Bauer,J. L. Nordstrom,H. Li,G. R. Chichili,P. A. Moor...

2017 annals of oncology DOI: 10.1093/annonc/mdx00... 170 views

15

Estrogen receptor-positive breast cancer in Japanese women: trends in incidence, characteristics, and prognosis

H. Yamashita,H. Iwase,T. Toyama,S. Takahashi,H. Sugiura,N. Yoshimoto,Y. Endo,Y. Fujii,S. Kobayashi;H...

2011 annals of oncology DOI: 10.1093/annonc/mdq59... 184 views

16

Author Correction: The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study

N. Özyurt; Ali Alkan; B. Gülbağcı; Mustafa Seyyar; Esra Aşık; Mustafa Şahbazlar; Mehmet Türker; Oğuz...

2025 Scientific reports DOI: 10.1038/s41598-024-8... 25 views

17

The prognostic impact of Her2 status in early triple negative breast cancer: a Turkish Oncology Group (TOG) study

N. Özyurt; Ali Alkan; B. Gülbağcı; Mustafa Seyyar; Esra Aydın; Mustafa Şahbazlar; Mehmet Türker; Oğu...

2024 Scientific reports DOI: 10.1038/s41598-024-7... 30 views

Related Research Groups

No Research Groups Found

No research groups are currently associated with this keyword.

Explore Related Keywords

apoptosis gastric cancer microsatellite instability cell cycle regulators invasiveness mucins multidrug resistance proteins neovascularization peritoneal spreading targeted therapy brain metastasis exome sequencing rna sequencing her3 genomic signature prognosis immunohistochemistry Oncology including cancer and carcinogens tumors